Stock listing

Argent Biopharma Ltd

Selected listing: H5O0 · SWB · EUR · DE

Argent Biopharma Ltd (Stuttgart:H5O0), Health Technology. Latest release Sep 30, 2026: Execution of Loan Facility Agreement.

H5O0:SWBEURDEUpdated October 2, 2026

Ticker: Stuttgart:H5O0
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Other
Exchange: Stuttgart
Currency: EUR

About Argent Biopharma Ltd

The company focuses on biopharmaceutical development and innovation. Its activities are centered around advancing healthcare solutions and addressing unmet medical needs.

Latest news from Argent Biopharma Ltd

Execution of Loan Facility Agreement

September 30, 2026

Argent Signs NLC Licence to Expand Antiviral Portfolio

September 28, 2026

Appendix 4E and 2026 Annual Report

August 31, 2026

FDA-CVM Establish INAD File for CannEpil Veterinary Program

August 25, 2026

US Veterinary Development Programme for CannEpil Commences

August 5, 2026

All Argent Biopharma Ltd news →

Research Argent Biopharma Ltd

Argent Biopharma Ltd company profile

View the public company page for Argent Biopharma Ltd on 6ix.

Argent Biopharma Ltd news

Read company news and market updates connected to Argent Biopharma Ltd.

Argent Biopharma Ltd investor events

Find investor webinars, events, and replay context for Argent Biopharma Ltd.